Related Experiment Video

Updated: May 31, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

The relationship between platelet reactivity and infarct-related artery patency in patients presenting with a

Nicoline J Breet1, Jochem W van Werkum, Heleen J Bouman

  • 1St. Antonius Center for Platelet Function Research, St. Antonius Hospital, Nieuwegein, the Netherlands.

Thrombosis and Haemostasis
|June 30, 2011
PubMed

Insights

Heightened platelet reactivity and higher leukocyte counts are linked to blocked arteries in ST-elevation myocardial infarction (STEMI) patients. Early antithrombotic therapy is crucial for restoring blood flow and improving outcomes.

Area of Science:

  • Cardiology
  • Hematology
  • Thrombosis

Background:

  • ST-elevation myocardial infarction (STEMI) is often associated with occluded infarct-related arteries (IRA) and heightened platelet reactivity, both linked to poor clinical outcomes.
  • The interplay between platelet function and IRA patency in STEMI patients remains incompletely understood.

Purpose of the Study:

  • To investigate the relationship between platelet reactivity and infarct-related artery (IRA) patency in patients presenting with ST-elevation myocardial infarction (STEMI).

Main Methods:

  • This study enrolled 99 STEMI patients, categorizing them into occluded (TIMI-flow 0-1) or patent (TIMI-flow 2-3) IRA groups based on initial angiography.
  • Platelet function was assessed using PFA-100 (COL/ADP) and light transmittance aggregometry (spontaneous, ADP, AA).
  • Multivariate analysis identified factors associated with IRA occlusion.

Main Results:

  • Forty-nine patients presented with an occluded IRA.
  • Independent predictors of IRA occlusion included shorter COL/ADP closure time (OR 0.60), increased 20 μM ADP-induced platelet aggregation (OR 1.77), and elevated leukocyte counts (OR 1.21).

Conclusions:

  • Heightened platelet reactivity and elevated leukocyte counts are significantly associated with IRA occlusion at presentation in STEMI patients.
  • These findings underscore the importance of early and potent antithrombotic therapy to achieve IRA recanalization and improve patient outcomes.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...